Health
BU researchers find how SARS-CoV-2 infection may drive deadly lung inflammation – News-Medical.Net
Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing.
Reviewed by Emily Henderson, B.Sc.Sep 21 2020
Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing. Specifically, access to primary human lung in vitro model systems is a priority since a variety of respiratory epithelial cells are the proposed targets of viral entry.
Now, a team of infectious disease, pulmonary and regenerative medicine researchers a…
-
Noosa News16 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoAbout 90,000 households remain without power after severe storms with giant hail lash south-east Queensland
-
General17 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General19 hours agoSister Kate’s site to become home to Perth’s first Aboriginal aged care facility